Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Xinxin Cao, Jian Li, MD, Ai-lin Zhao, Xue-min Gao, Hua-cong Cai, MD, Lu Zhang, MD, Yan Zhang, MD, Jun Feng, MD, Miao Chen, MD, Tie-nan Zhu, MD, Na Niu, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Ming-hui Duan, MD

Blood (2019) 134 (Supplement_1): 294.

https://doi.org/10.1182/blood-2019-122220

Published: 2019

Journal Articles

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Changju Qu, PhD, Nana Ping, MD, PhD, Danqing Kong, MD, Fan Xia, MD, Depei Wu, MD PhD, Zhengming Jin, MD

Blood (2019) 134 (Supplement_1): 5338.

https://doi.org/10.1182/blood-2019-128111

Published: 2019

Journal Articles

Treatment Outcomes in the Management of Lymphoblastic Lymphoma (LBL) in Adults: An Institutional Review

Rohan Kehar, MDMSc, Vishal Kukreti, MD FRCP(C), Michael Crump, MD, Melania Pintilie, MSc, John Kuruvilla, MD

Blood (2017) 130 (Supplement 1): 4156.

https://doi.org/10.1182/blood.V130.Suppl_1.4156.4156

Published: 2017

Journal Articles

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Henrik Gregersen, MD, Niels Abildgaard, MD, Trung Hieu Do, MD, Ida Bruun Kristensen, MD, Ulf Christian Frølund, MD, Niels Frost Andersen, MD, Lene Kongsgaard Nielsen, MD, Christen Lykkegaard Andersen, MD, Tobias Wirenfeldt Klausen, M.S., Annette Juul Vangsted, MD

Blood (2017) 130 (Supplement 1): 3129.

https://doi.org/10.1182/blood.V130.Suppl_1.3129.3129

Published: 2017

Journal Articles

The Experience in Treating Elders with AML Using High-Dose AraC.

Cesar Rodriguez, MD, Roger Herzig, MD, Geoffrey P. Herzig, MD

Blood (2016) 128 (22): 5201.

https://doi.org/10.1182/blood.V128.22.5201.5201

Published: 2016

Journal Articles

Increased Risk of Sternal Complications in Patients with Plasma Cell Dyscrasias (PCDs) Undergoing Coronary Artery Bypass Graft (CABG)

Malini M Patel, MD, Shams B Bufalino, MD, Anai N Kothari, MD, Paul C Kuo, MD, Sucha Nand, MD

Blood (2015) 126 (23): 5319.

https://doi.org/10.1182/blood.V126.23.5319.5319

Published: 2015

Journal Articles

Outcome of Gastric Diffuse Large B-Cell Lymphoma and Usefulness of PET-CT in Detecting Gastric Lesion

Tomohiro Kadota, MD, Sachiko Seo, MD PhD, Yoshihiro Nakagami, MD, Hiroe Fuse, MD, Yujiro Ueda, MD, Genichiro Ishii, MD PhD, Kuniaki Itoh, MD, Tomonori Yano, MD, Kazuhiro Kaneko, MD PhD, Kunihiro Tsukasaki, MD, PhD

Blood (2015) 126 (23): 2715.

https://doi.org/10.1182/blood.V126.23.2715.2715

Published: 2015

Journal Articles

Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma

Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD

Blood (2013) 122 (21): 3034.

https://doi.org/10.1182/blood.V122.21.3034.3034

Published: 2013

Journal Articles

Incidence Of Hypotension In Patients With Multiple Myeloma During High Dose Chemotherapy and Autologous Stem Cell Rescue

Priya Sehgal, BA, Noa Biran, MD, Gagan Sahni, MD, Ajai Chari, MD

Blood (2013) 122 (21): 3324.

https://doi.org/10.1182/blood.V122.21.3324.3324

Published: 2013

Journal Articles

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

Blood (2013) 122 (21): 685.

https://doi.org/10.1182/blood.V122.21.685.685

Published: 2013

Journal Articles

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Saro Armenian, D.O., M.P.H., Can-Lan Sun, PhD, Mukta Arora, MD, MS, K. Scott Baker, MD, MS, Liton Francisco, Joseph Rosenthal, MD, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, Ph.D.

Blood (2013) 122 (21): 553.

https://doi.org/10.1182/blood.V122.21.553.553

Published: 2013

Journal Articles

Clinical Phase II Study of a Non-Anthracycline-Based Immunochemotherapy Regimen(R-GemOx) As First-Line Treatment in Elderly Patients with Diffuse Large B-Cell Lymphoma

Lei Fan, M.D., Ph.D., Li Wang, M.D., Ji Xu, M.D., Run Zhang, M.D., Rong Wang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD

Blood (2012) 120 (21): 3667.

https://doi.org/10.1182/blood.V120.21.3667.3667

Published: 2012

Journal Articles

Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation.

Nelli Bejanyan, MD, Aleksandr Lazaryan, MD, PhD, MPH, Lisa Rybicki, MS, Shawnda Tench, Steven Andresen, DO, Ronald Sobecks, MD, Robert Dean, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2010) 116 (21): 1532.

https://doi.org/10.1182/blood.V116.21.1532.1532

Published: 2010

Journal Articles

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Saro Armenian, DO, MPH, Can-Lan Sun, Ph.D., Toana Kawashima, MS, Mukta Arora, MD, Wendy Leisenring, ScD, Charles A. Sklar, MD, K. Scott Baker, MD, MS, Liton Francisco, Jennifer Berano Teh, MD, George Mills, III, F. Lennie Wong, PhD, Joseph Rosenthal, MD, Lisa Diller, MD, Melissa M. Hudson, MD, Kevin C. Oeffinger, MD, Leslie L. Robison, PhD, Smita Bhatia, MD, MPH

Blood (2010) 116 (21): 217.

https://doi.org/10.1182/blood.V116.21.217.217

Published: 2010

Journal Articles

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients.

Blood (2009) 114 (22): 128.

https://doi.org/10.1182/blood.V114.22.128.128

Published: 2009

Journal Articles

A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients

Antonio Palumbo, MD, Sara Bringhen, MD, Davide Rossi, MD, Valeria Magarotto, MD, Francesco Di Raimondo, MD, Roberto Ria, MD, Massimo Offidani, MD, Chiara Nozzoli, MD, Francesca Patriarca, Vincenzo Callea, MD, Giulia Benevolo, MD, Roberto Marasca, MD, Tommasina Guglielmelli, MD, Manuela Rizzo, MD, Mariella Grasso, MD, Maria Teresa Petrucci, MD, Paola Omedè, PhD, Gianluca Gaidano, MD, Mario Boccadoro, MD

Blood (2008) 112 (11): 652.

https://doi.org/10.1182/blood.V112.11.652.652

Published: 2008

Journal Articles

Safety and Effectiveness of Prophylactic Intravenous Itraconazole in Pediatric Stem Cell Transplantation Recipients.

Chuhl Joo Lyu, MD, PhD, Sung Chul Won, MD, Seung-Hwan Oh, MD, PhD, Jung Woo Han, MD, Seung Yun Kwon, MD, Jong Hee Ko, PharmD, Yoon Jung Shin, RN

Blood (2007) 110 (11): 4996.

https://doi.org/10.1182/blood.V110.11.4996.4996

Published: 2007

Journal Articles

Cytoprotective Effect of Palifermin on Gastrointestinal Mucous Membrane Enabled Non-Myeloablative Chemotherapy Administration in ALL Patient with High Risk of Gastrointestinal Toxicity.

Kajetana Foryciarz, MD, Tomasz Sacha, MD PhD, Patrycja Mensah-Glanowska, MD PhD, Agnieszka Balana-Nowak, PhD, Aleksander Skotnicki

Blood (2007) 110 (11): 4332.

https://doi.org/10.1182/blood.V110.11.4332.4332

Published: 2007

Journal Articles

Intussusception in Childhood Acute T Cell Lymphoblastic Leukemia: An Unusual Complication - Report of 2 Cases.

Jesika Shah, MD, Dan Barlev, MD, Arlene Sara Redner, MD, Ashok Shende, MD, Gungor Karayalcin, MD

Blood (2006) 108 (11): 4530.

https://doi.org/10.1182/blood.V108.11.4530.4530

Published: 2006

Journal Articles

Bendamustine HCl (TREANDA TM ) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin’s Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).

Katherine Sue Robinson, MD, Michael E. Williams, MD, Philip Cohen, MD, Anil Tulpule, MD, Richard H. van der Jagt, MD, Jordan A. Herst, MD, Robin M. Joyce, MD, Alberto Bessudo, MD, Bernard Lemieux, MD, Lee S. Schwartzberg, MD, Jennifer Oliver, MD, Ely Benaim, MD

Blood (2005) 106 (11): 923.

https://doi.org/10.1182/blood.V106.11.923.923

Published: 2005

NARROW

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Treatment Outcomes in the Management of Lymphoblastic Lymphoma (LBL) in Adults: An Institutional Review

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

The Experience in Treating Elders with AML Using High-Dose AraC.

Increased Risk of Sternal Complications in Patients with Plasma Cell Dyscrasias (PCDs) Undergoing Coronary Artery Bypass Graft (CABG)

Outcome of Gastric Diffuse Large B-Cell Lymphoma and Usefulness of PET-CT in Detecting Gastric Lesion

Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma

Incidence Of Hypotension In Patients With Multiple Myeloma During High Dose Chemotherapy and Autologous Stem Cell Rescue

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Clinical Phase II Study of a Non-Anthracycline-Based Immunochemotherapy Regimen(R-GemOx) As First-Line Treatment in Elderly Patients with Diffuse Large B-Cell Lymphoma

Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation.

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients.

A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients

Safety and Effectiveness of Prophylactic Intravenous Itraconazole in Pediatric Stem Cell Transplantation Recipients.

Cytoprotective Effect of Palifermin on Gastrointestinal Mucous Membrane Enabled Non-Myeloablative Chemotherapy Administration in ALL Patient with High Risk of Gastrointestinal Toxicity.

Intussusception in Childhood Acute T Cell Lymphoblastic Leukemia: An Unusual Complication - Report of 2 Cases.

Bendamustine HCl (TREANDA TM ) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin’s Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only